Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (18)
A systematic review of genetic polymorphisms and breast cancer risk.
1999 • 543 citations
Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17
1994 • 467 citations
Cloning and Sequence of the Human Gene for P450cl7 (Steroid 17α-Hydroxylase/17,20 Lyase): Similarity with the Gene for P450c21
1987 • 415 citations
Estrogens and breast cancer
1996 • 343 citations
Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
1999 • 299 citations
A polymorphism in the CYP17 gene increases the risk of breast cancer.
1997 • 250 citations
Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.
1998 • 243 citations
The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.
1999 • 228 citations
CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1.
1999 • 154 citations
Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status
1996 • 128 citations
Tissue-Specific, Cyclic Adenosine 3′,5′-Monophosphate-lnduced, and Phorbol Ester-Repressed Transcription from the Human P450c17 Promoter in Mouse Cells
1990 • 122 citations
No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer
1998 • 118 citations
Association betweenCYP17 gene polymorphism and risk of breast cancer in young women
1999 • 108 citations
CYP17 genotype and breast cancer risk.
1998 • 97 citations
A polymorphism in the CYP17 gene is associated with male breast cancer
1999 • 96 citations
Association between CYP17 polymorphisms and the development of breast cancer.
1998 • 95 citations
Genetic polymorphisms and risk of breast cancer.
1999 • 75 citations
Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy.
1999 • 71 citations